Efficacy of icatibant in type I and II acquired angioedema

被引：0
|
作者：
Capelo, A. [1 ]
Nascimento, L. [1 ]
Silva, E. [2 ]
Chieza, C. [1 ]
Silva, W. [2 ]
Neves, R. [1 ]
机构：
[1] Hosp Univ Gaffree & Guinle, Rio De Janeiro, Brazil
[2] HUGG, Rio De Janeiro, Brazil
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
000210
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Rapid Resolution of Erythema Marginatum after Icatibant in Acquired Angioedema
    Bygum, Anette
    Broesby-Olsen, Sigurd
    ACTA DERMATO-VENEREOLOGICA, 2011, 91 (02) : 185 - 186
  • [22] An evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and II
    Floccard, Bernard
    Hautin, Etienne
    Bouillet, Laurence
    Coppere, Brigitte
    Allaouchiche, Bernard
    CORE EVIDENCE, 2012, 7 : 105 - 114
  • [23] ACQUIRED AUTOIMMMUNE ANGIOEDEMA TYPE II: A CASE REPORT
    Randolph, C. C.
    Wall, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (05) : A85 - A86
  • [24] Acquired Angioedema Presenting With Biochemical Features Suggestive Of Type II Hereditary Angioedema
    Vaitla, Prashantha
    Jolles, Stephen
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2015, 182 : 19 - 20
  • [25] Self-administration of icatibant in acute attacks of Type I hereditary angioedema: A case report and review of hereditary angioedema
    Piras, Viviana
    Alves, Francisca
    Goncalo, Margarida
    DERMATOLOGIC THERAPY, 2019, 32 (06)
  • [26] Elderly vs younger patients (pts) with hereditary angioedema type I/II: safety analysis from the icatibant outcomes survey
    Longhurst, H. J.
    Bouillet, L.
    Aberer, W.
    Caballero, T.
    Grumach, A. S.
    Maurer, M.
    Zanichelli, A.
    Bygum, A.
    Pommie, C.
    Andresen, I
    ALLERGY, 2017, 72 : 593 - 594
  • [27] ICATIBANT FOR HEREDITARY ANGIOEDEMA
    Gras, Jordi
    DRUGS OF TODAY, 2009, 45 (12) : 855 - 864
  • [28] Icatibant in the treatment of angiotensin II receptor blocker induced angioedema
    Strassen, U.
    Bas, M.
    Hoffmann, T.
    Greve, J.
    ALLERGY, 2012, 67 : 359 - 359
  • [29] Successful and Safe Use Of Icatibant For Life-Threatening Angioedema Attack During Pregnancy In a Patient With Hereditary Angioedema Type I
    Boufleur, Karine
    Delcaro, Luana
    Cordeiro, Daniel L.
    Botelho Palhas, Priscila B.
    de Melo Sousa, Janaina Fernandes
    Mendonca, Thais
    de Lima Melo, Janaina Michele
    Neppelenbroek, Gustavo
    Sarti, Wlly
    Moreno, Adriana S.
    Arruda, Luisa Karla P.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB36 - AB36
  • [30] Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey
    Bygum, Anette
    Caballero, Teresa
    Grumach, Anete S.
    Longhurst, Hilary J.
    Bouillet, Laurence
    Aberer, Werner
    Zanichelli, Andrea
    Botha, Jaco
    Andresen, Irmgard
    Maurer, Marcus
    Grumach, A. S.
    Bygum, A.
    Delaunay, C. Blanchard
    Boccon-Gibod, I
    Bouillet, L.
    Coppere, B.
    Du Thanh, A.
    Dzviga, C.
    Fain, O.
    Goichot, B.
    Gompel, A.
    Guez, S.
    Jeandel, P. Y.
    Kanny, G.
    Launay, D.
    Maillard, H.
    Martin, L.
    Masseau, A.
    Ollivier, Y.
    Sobel, A.
    Aygoeren-Puersuen, E.
    Bas, M.
    Bauer, M.
    Bork, K.
    Greve, J.
    Magerl, M.
    Martinez-Saguer, I
    Maurer, M.
    Strassen, U.
    Papadopoulou-Alataki, E.
    Psarros, F.
    Graff, Y.
    Kivity, S.
    Reshef, A.
    Toubi, E.
    Arcoleo, F.
    Bova, M.
    Cicardi, M.
    Nconi, P. Ma
    Marone, G.
    CLINICAL AND TRANSLATIONAL ALLERGY, 2019, 9
12345